Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: TDCS and Aphasia Therapy in the Chronic Phase After Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transcranial direct current stimulation (TDCS) with aphasia therapy in the chronic post-stroke phase was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Ghent | Conditions: Aphasia Following Cerebral Infarction, Aphasia Following Nontraumatic Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED